CIPROFLOXACIN TEVA ® INFUSION BAGS 2 MG/ML
Country: Iżrael
Lingwa: Ingliż
Sors: Ministry of Health
Xi dokumenti għal dan il-prodott mhumiex disponibbli bħalissa, tista 'tibgħat talba lis-servizz tal-konsumatur tagħna u aħna ninnotifikawkom malli nkunu nistgħu niksbuhom.
Ibgħat talba.
Ibgħat talba.
Ingredjent attiv:
CIPROFLOXACIN AS LACTATE 2 MG / 1 ML
Disponibbli minn:
SALOMON,LEVIN & ELSTEIN LTD
Kodiċi ATC:
S03AA07
Għamla farmaċewtika:
SOLUTION FOR INFUSION
Rotta amministrattiva:
I.V
Manifatturat minn:
TEVA PHARMACEUTICAL WORKS PRIVATE LIMITED COMPANY, HUNGARY
Grupp terapewtiku:
CIPROFLOXACIN
Indikazzjonijiet terapewtiċi:
Adults:Uncomplicated and complicated infections caused by ciprofloxacin sensitive pathogens.Children: For the treatment of acute pulmonary exacerbation of cystic fibrosis associated with Pseudomonas aeroginosa infections in pediatric patients aged 5-17 years.
Data ta 'l-awtorizzazzjoni:
2011-10-01
